From infectious diseases to personalised medicine, India enters futuristic healthcare phase: Dr Jitendra Singh

• Union MoS (I/C) Science & Technology Dr Jitendra Singh asserted India is shifting from an infectious-disease focus to personalised/precision medicine, anchored in genomics, biotech and rare-disease care.
• Announcement made while laying foundation stone of SAMARTH Skill Centre and inaugurating the iDEA-NA BRIC-CDFD Technology Incubator at DBT-CDFD, Hyderabad on 9 Jan 2026.
• Connects to GS-II (Health policy) and GS-III (Biotech, S&T) — overlaps with National Policy for Rare Diseases 2021, BIRAC, BioE3 Policy, Genome India Project.